The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines
出版年份 2020 全文链接
标题
The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines
作者
关键词
-
出版物
Cell Death & Disease
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-01-16
DOI
10.1038/s41419-020-2225-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transketolase deficiency protects the liver from DNA damage by increasing levels of ribose 5-phosphate and nucleotides
- (2019) Minle Li et al. CANCER RESEARCH
- Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway
- (2018) Chien-Wei Tseng et al. CANCER RESEARCH
- Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway
- (2017) Jiwei Zhang et al. HEPATOLOGY
- Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling
- (2016) Lina Sun et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Transketolase counteracts oxidative stress to drive cancer development
- (2016) Iris Ming-Jing Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bile acid signaling and liver regeneration
- (2015) Mingjie Fan et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation
- (2015) Carmela Ricciardelli et al. CLINICAL & EXPERIMENTAL METASTASIS
- FXR and liver carcinogenesis
- (2014) Xiong-fei Huang et al. ACTA PHARMACOLOGICA SINICA
- Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics
- (2013) Q. Huang et al. CANCER RESEARCH
- HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
- (2013) Gregg L. Semenza JOURNAL OF CLINICAL INVESTIGATION
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer
- (2012) Yanjun Jiang et al. HEPATOLOGY
- FXR Controls the Tumor Suppressor NDRG2 and FXR Agonists Reduce Liver Tumor Growth and Metastasis in an Orthotopic Mouse Xenograft Model
- (2012) Ulrich Deuschle et al. PLoS One
- HDAC3 and the molecular brake pad hypothesis
- (2011) Susan C. McQuown et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1α-induced metabolic reprograming
- (2010) F Zhao et al. ONCOGENE
- Inhibition of Endothelin-1-Mediated Contraction of Hepatic Stellate Cells by FXR Ligand
- (2010) Jiang Li et al. PLoS One
- Nuclear Bile Acid Receptor FXR Protects against Intestinal Tumorigenesis
- (2008) S. Modica et al. CANCER RESEARCH
- Mechanisms of Cholestasis
- (2008) Gernot Zollner et al. Clinics in Liver Disease
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now